{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T17:01:23Z","timestamp":1791219683774,"version":"4.1.0"},"reference-count":48,"publisher":"Informa UK Limited","issue":"18","funder":[{"name":"Wellcome Laboratories"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Future Med. Chem."],"published-print":{"date-parts":[[2012,12]]},"DOI":"10.4155\/fmc.12.177","type":"journal-article","created":{"date-parts":[[2012,12,12]],"date-time":"2012-12-12T17:23:26Z","timestamp":1355333006000},"page":"2311-2323","source":"Crossref","is-referenced-by-count":58,"title":["Exploration Of 4(\n            <i>1H<\/i>\n            )-Pyridones As A Novel Family Of Potent Antimalarial Inhibitors Of The Plasmodial Cytochrome bc1"],"prefix":"10.1080","volume":"4","author":[{"given":"Jos\u00e9 M","family":"Bueno","sequence":"first","affiliation":[{"name":"GlaxoSmithKline, Tres Cantos Medicines Development Campus, Diseases of the Developing World. C\/Severo Ochoa, 2, 28760-Tres Cantos, Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Esperanza","family":"Herreros","sequence":"additional","affiliation":[{"name":"GlaxoSmithKline, Tres Cantos Medicines Development Campus, Diseases of the Developing World. C\/Severo Ochoa, 2, 28760-Tres Cantos, Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I\u00f1igo","family":"Angulo-Barturen","sequence":"additional","affiliation":[{"name":"GlaxoSmithKline, Tres Cantos Medicines Development Campus, Diseases of the Developing World. C\/Severo Ochoa, 2, 28760-Tres Cantos, Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Santiago","family":"Ferrer","sequence":"additional","affiliation":[{"name":"GlaxoSmithKline, Tres Cantos Medicines Development Campus, Diseases of the Developing World. C\/Severo Ochoa, 2, 28760-Tres Cantos, Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 M","family":"Fiandor","sequence":"additional","affiliation":[{"name":"GlaxoSmithKline, Tres Cantos Medicines Development Campus, Diseases of the Developing World. C\/Severo Ochoa, 2, 28760-Tres Cantos, Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francisco J","family":"Gamo","sequence":"additional","affiliation":[{"name":"GlaxoSmithKline, Tres Cantos Medicines Development Campus, Diseases of the Developing World. C\/Severo Ochoa, 2, 28760-Tres Cantos, Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Domingo","family":"Gargallo-Viola","sequence":"additional","affiliation":[{"name":"GlaxoSmithKline, Tres Cantos Medicines Development Campus, Diseases of the Developing World. C\/Severo Ochoa, 2, 28760-Tres Cantos, Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Geo","family":"Derimanov","sequence":"additional","affiliation":[{"name":"GlaxoSmithKline, Diseases of the Developing World, 1250 South Collegeville Road (UP-1345). Collegeville, PA19426, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2012,12,12]]},"reference":[{"key":"e_1_3_4_3_1_1","first-page":"389","article-title":"When is enough enough? The need for a robust pipeline of high-quality antimalarials.","volume":"9","author":"Wells TN","year":"2010","unstructured":"Wells TN , PollEM. When is enough enough? The need for a robust pipeline of high-quality antimalarials.Discov. Med.9, 389\u2013398 (2010).","journal-title":"Discov. Med."},{"key":"e_1_3_4_3_2_1","doi-asserted-by":"publisher","DOI":"10.1038\/clpt.2009.51"},{"key":"e_1_3_4_3_3_1","doi-asserted-by":"publisher","DOI":"10.1038\/nrmicro2331"},{"key":"e_1_3_4_3_4_1","doi-asserted-by":"publisher","DOI":"10.1002\/cmdc.201000341"},{"key":"e_1_3_4_3_5_1","doi-asserted-by":"crossref","unstructured":"Burrows JN WatersonD. Discovering new medicines to control and eradicate malaria. In: Third World Diseases: Topics in Medicinal Chemistry Vol. 7. Elliott RL (Ed.). Springer-Verlag Berlin-Heidelberg Germany 125\u2013180 (2011).","DOI":"10.1007\/7355_2011_14"},{"key":"e_1_3_4_3_6_1","doi-asserted-by":"publisher","DOI":"10.2174\/092986710790820660"},{"key":"e_1_3_4_3_7_1","doi-asserted-by":"publisher","DOI":"10.2174\/138945007779315632"},{"key":"e_1_3_4_3_8_1","doi-asserted-by":"publisher","DOI":"10.1038\/nature05572"},{"key":"e_1_3_4_3_9_1","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-4615-0059-9_9"},{"key":"e_1_3_4_3_10_1","doi-asserted-by":"publisher","DOI":"10.1038\/nature01097"},{"key":"e_1_3_4_3_11_1","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M304042200"},{"key":"e_1_3_4_3_12_1","doi-asserted-by":"publisher","DOI":"10.1054\/drup.2000.0157"},{"key":"e_1_3_4_3_13_1","doi-asserted-by":"publisher","DOI":"10.1186\/1475-2875-1-1"},{"key":"e_1_3_4_3_14_1","doi-asserted-by":"publisher","DOI":"10.4269\/ajtmh.1999.60.533"},{"key":"e_1_3_4_3_15_1","doi-asserted-by":"publisher","DOI":"10.1021\/cb200105d"},{"key":"e_1_3_4_3_16_1","doi-asserted-by":"publisher","DOI":"10.1021\/jm200718m"},{"key":"e_1_3_4_3_17_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.exppara.2010.10.016"},{"key":"e_1_3_4_3_18_1","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00486-12"},{"key":"e_1_3_4_3_19_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1205651109"},{"key":"e_1_3_4_3_20_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.chembiol.2011.09.016"},{"key":"e_1_3_4_3_21_1","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jis184"},{"key":"e_1_3_4_3_22_1","doi-asserted-by":"publisher","DOI":"10.1021\/jm00281a029"},{"key":"e_1_3_4_3_23_1","doi-asserted-by":"publisher","DOI":"10.1016\/0006-2952(84)90480-5"},{"key":"e_1_3_4_3_24_1","doi-asserted-by":"publisher","DOI":"10.1021\/jm00261a033"},{"key":"e_1_3_4_3_25_1","doi-asserted-by":"publisher","DOI":"10.1021\/jm0705760"},{"key":"e_1_3_4_3_26_1","unstructured":"Steck EA . Chemotherapy of Malaria. Division of Medicinal Chemistry Walter Reed Army Institute of Research US Government Printing Office Washington DC USA (1972)."},{"key":"e_1_3_4_3_27_1","unstructured":"Wiselogle FY . A survey of antimalarial drugs 1941\u20131945. Edwards JW (Ed.). Ann Harbor MI USA 1\u20131921 (1946)."},{"key":"e_1_3_4_3_28_1","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.16.6.710"},{"key":"e_1_3_4_3_29_1","doi-asserted-by":"publisher","DOI":"10.1016\/0035-9203(92)90220-7"},{"issue":"6","key":"e_1_3_4_3_30_1","first-page":"30","article-title":"Strong anti-liver stage activity of a novel 4(1H)-pyridone antimalarial compound. Program and Abstracts of the 54th Annual Meeting of the ASTMH.","volume":"73","author":"Hez-Deroubaix S","year":"2005","unstructured":"Hez-Deroubaix S , BentchikouE, BlancC, GriponP, BelghitiJet al. Strong anti-liver stage activity of a novel 4(1H)-pyridone antimalarial compound. Program and Abstracts of the 54th Annual Meeting of the ASTMH. Am. J. Trop. Med. Hyg. 73(Suppl. 6), 30 (2005).","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"e_1_3_4_3_31_1","unstructured":"Pudney M YeatesC PearceJ JonesL FryM. New 4-pyridone antimalarials which potentiate the activity of atovaquone (566C80). Abstracts and Programme Vol 2 Proceedings of the 13th International Congress for Tropical Medicine and Malaria Pattaya Thailand Nov 29\u2013Dec 4 149 (1992)."},{"issue":"5","key":"e_1_3_4_3_32_1","first-page":"248","article-title":"Preclinical pharmacokinetics and metabolism of GW308678, a second generation 4(1H)-pyridone anti-malarial mitochondrial electron transport inhibitor. Program and Abstracts of the 55th Annual Meeting of the ASTMH.","volume":"75","author":"Xiang H","year":"2006","unstructured":"Xiang H , Surdy-FreedJ, SubbanagounderGet al. Preclinical pharmacokinetics and metabolism of GW308678, a second generation 4(1H)-pyridone anti-malarial mitochondrial electron transport inhibitor. Program and Abstracts of the 55th Annual Meeting of the ASTMH. Am. J. Trop. Med. Hyg. 75(Suppl. 5), 248 (2006)","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"e_1_3_4_3_33_1","doi-asserted-by":"publisher","DOI":"10.1002\/jps.20681"},{"key":"e_1_3_4_3_34_1","doi-asserted-by":"publisher","DOI":"10.1002\/jps.22217"},{"key":"e_1_3_4_3_35_1","doi-asserted-by":"publisher","DOI":"10.2174\/0929867013372643"},{"key":"e_1_3_4_3_36_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0928-0987(00)00181-0"},{"key":"e_1_3_4_3_37_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bmcl.2011.07.044"},{"key":"e_1_3_4_3_38_1","doi-asserted-by":"publisher","DOI":"10.1093\/toxsci\/kfm052"},{"key":"e_1_3_4_3_39_1","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00519-09"},{"key":"e_1_3_4_3_40_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0169-409X(00)00118-6"},{"key":"e_1_3_4_3_41_1","doi-asserted-by":"crossref","unstructured":"Heimbach T FleisherD KaddoumiA. overcoming poor aqueous solubility of drugs by oral delivery. In: Prodrugs: Challenges and Rewards Part 1. Springer New York NY USA 157 (2007).","DOI":"10.1007\/978-0-387-49785-3_5"},{"key":"e_1_3_4_3_42_1","doi-asserted-by":"publisher","DOI":"10.1517\/14656566.5.9.1995"},{"key":"e_1_3_4_3_43_1","doi-asserted-by":"publisher","DOI":"10.1021\/jm00163a016"},{"key":"e_1_3_4_3_44_1","doi-asserted-by":"publisher","DOI":"10.1002\/jps.2600820115"},{"key":"e_1_3_4_3_45_1","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.48.3.791-798.2004"},{"key":"e_1_3_4_3_46_1","doi-asserted-by":"crossref","unstructured":"McComb RB BowersGNJ PosenS. Alkaline Phosphatase. Plenum Press New York USA and London UK (1979).","DOI":"10.1007\/978-1-4613-2970-1"},{"key":"e_1_3_4_3_47_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cbpa.2010.05.005"},{"key":"e_1_3_4_4_2_1","unstructured":"MMV target product profiles. www.mmv.org\/research-development\/essential-information-scientists\/target-product-profiles"}],"container-title":["Future Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.4155\/fmc.12.177","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,23]],"date-time":"2024-05-23T19:51:41Z","timestamp":1716493901000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.4155\/fmc.12.177"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,12]]},"references-count":48,"journal-issue":{"issue":"18","published-print":{"date-parts":[[2012,12]]}},"alternative-id":["10.4155\/fmc.12.177"],"URL":"https:\/\/doi.org\/10.4155\/fmc.12.177","relation":{},"ISSN":["1756-8919","1756-8927"],"issn-type":[{"value":"1756-8919","type":"print"},{"value":"1756-8927","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,12]]}}}